Treatment of ulcerative colitis using fecal bacteriotherapy

Journal of Clinical Gastroenterology

Volumn 37, Issue 1, 2003, Pages 42-47

  Borody, Thomas J ^a   Warren, Eloise F ^b   Leis, Sharyn ^b   Surace, Rosa ^b   Ashman, Ori ^b  

^a Centre for Digestive Diseases   (Australia)

^b NONE

Author keywords

Bacteriotherapy; Inflammatory bowel disease; Intestinal flora; Probiotics; Ulcerative colitis

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; MACROGOL; PROBIOTIC AGENT;

ADULT; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE; COLON FLORA; COLONOSCOPY; FECES MICROFLORA; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATORY CELL; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; MALE; MEDIATOR RELEASE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADMINISTRATION, RECTAL; ADULT; COLITIS, ULCERATIVE; FECES; FEMALE; HUMANS; INTESTINES; MALE; MIDDLE AGED; PROBIOTICS;

EID: 0038613653     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200307000-00012     Document Type: Article

References (48)

1. Eiseman B, Silen W, Bascom GS. et al. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery. 1958;44:854-859.
2. Bowden TA, Mansberger AR, Lykins LE. Pseudomembranous enterolcolitis: Mechanism of restoring floral homeostasis. Am Surgeon. 1981;47:178-183.
3. Schwan A, Sjolin S, Trottestam U. Relapsing Clostridium difficile enterocolitis cured by rectal infusion of homologous faeces. Lancet. 1983;2:845.
4. Tvede M, Rask-Madsen J. Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet. 1989;1:1156-1160.
5. Flotterod O, Hopen G. Refractory Clostridium difficile infection. Untraditional treatment of antibiotic-induced colitis. Tidsskr Nor Laegeforen. 1991;111:1364-1365.
6. Borody TJ. Flora power - Fecal bacteria cure chronic C. difficile diarrhea. Am J Gastroenterol. 2000;95:3028-3029.
7. Faust G, Langelier D, Haddad H, et al. Treatment of recurrent pseudomembranous colitis with stool transplantation: Report of six cases. Can J Gastroenterol. 2002;16:A43.
8. Persky SE, Brandt LJ. Treatment of recurrent Clostridium difficile-associated diarrhea by administration of donated stool directly through a colonoscope. Am J Gastroenterol. 2000;95:3283-3285.
9. Gustafsson A, Lund-Tonnesen S, Berstad A, et al. Fecal short-chain fatty acids in patients with antibiotic-associated diarrhea, before and after fecal enema treatment. Scand J Gastroenterol. 1998;33:721-727.
10. Gustafsson A, Berstad A, Lund-Tonnesen S, et al. The effect of fecal enema on five microflora-associated characteristics in patients with antibiotic-associated diarrhea. Scand J Gastroenterol. 1999;34:580-586.
11. Bennet JD, Brinkman M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet. 1989;1:164.
12. Andrews PJ, Borody TJ. Putting back the bugs: Bacterial treatment relieves chronic constipation and symptoms of irritable bowel syndrome. Med J Aust. 1993;159:633-634.
13. Andrews PJ, Barnes P, Borody TJ, et al. Chronic constipation reversed by restoration of bowel flora. A case and a hypothesis. Eur J Gastroenterol Hepatol. 1992;4:245-247.
14. Borody TJ, George L, Andrews PJ, et al. Bowel flora alteration: A potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust, 1989;150:604.
15. Campieri M, Gionchetti P. Probiotics in inflammatory bowel disease: New insight to pathogenesis or a possible therapeutic alternative. Gastroenterology. 1999;116:1246-1260.
16. Fiocchi C. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology. 1998;115:182-205.
17. Hamilton-Miller JMT. A review of clinical trials of probiotics in the management of inflammatory bowel disease. Infect Dis Rev. 2001;3:83-87,
18. Anderson M. Crohn's: An autoimmune or bacterial-related disease? The Scientist, 2001;15:22.
19. Sartor RB. The influence of normal microbial flora on the development of chronic mucosal inflammation. Res Immunol. 1997;148:567-576.
20. Duchmann R, Kaiser I, Hermann E, et al, Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol. 1995;102:448-455.
21. Hollander D. Permeability in Crohn's disease: altered barrier function in healthy relatives? Gastroenterology. 1993;104:1848-1851.
22. Campieri M, Gionchetti P. Bacteria as the cause of ulcerative colitis. Gut. 2001;48:132-135.
23. Ohkusa T, Sato N, Ogihara T, et al. Fusobacterium varium localised in the colonic mucosa of patients with ulcerative colitis stimulates species-specific antibody. J Gostroenterol Hepatol. 2002;17:849-853.
24. Rutgeers P, Geboes K, Ponette E, et al. Acute infective colitis caused by endemic pathogens in Western Europe: Endoscopic features. Endoscopy. 1982;14:212-219.
25. Vantrappen G, Ponette E, Geboes K, et al. Yersinia enteritis and enterocolitis: Gastroenterological aspects. Gastroenterology. 1977;72:220-227.
26. Loss RW, Manglia JC, Pereira M. Campylobacter colitis presenting as inflammatory bowel disease with segmental colonic ulcerations. Gastroenterology. 1980;79:138-140.
27. Tucker PC, Webster PD, Kilpatrick ZM. Amebic colitis mistaken for inflammatory bowel disease. Arch Intern Med. 1975;135:681-685.
28. Shein RS, Gelb A. Colitis due to Dientamoeba fragilis. Am J Gastroenterol. 1983;78:634-636.
29. Wells CL, Maddaus MA, Jechorek RP, et al. Role of intestinal anaerobic bacteria in colonization resistance. Eur J Clin Microbiol Infect Dis. 1988;7:107-113.
30. Onderdonk AB, Cisneros RL, Bartlett JG. Clostridium difficile in gnotobiotic mice. Infect Immun. 1980;28:277-282.
31. van der Wiel-Korstanje J, Winkler KC. The faecal flora in ulcerative colitis. J Med Microbiol. 1975;8:491-501.
32. Burke DA, Axon ATR. Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea. Br Med J. 1988;279:102-107.
33. van der Waaij D, Berguis-de Vries JM, Lekkerkerk-van der Wees JEC. Colonisation resistance of the digestive tract in conventional and antibiotic-treated mice. J Hyg. 1971;69:405-411.
34. Blomberg L, Henriksson A, Conway PL. Inhibition of Escherichia coli K88 to piglet ileal mucus by Lactobacillus spp. Appl Environ Microbiol. 1993;59:34-39.
35. Percival AK. Incidence and mechanisms of transfection of R-factors in bacteria. PhD thesis. Melbourne: Alfred Hospital; 1975.
36. Sullivan NM, Mills DC, Riemann HP, et al. Inhibitions of growth of Clostridium botulinum by intestinal microflora isolated from healthy infants. Microb Ecol Health Dis. 1988;1:179-192.
37. Silva M, Jacobus NV, Deneke C, et al. Antimicrobial substance from a human lactobacillus strain. Antimicrob Agents Chemother. 1987;31:1231-1233.
38. Malamou-Ladas H, Tabaqchali S. Inhibition of Clostridium difficile by faecal streptococci. J Med Microbiol. 1980;15:565-574.
39. Torres JF, Camorlinga M, Munoz O. Inhibitory activity of fecal flora against the multiplication of Clostridium difficile. Arch Invest Med. 1986;17:147-156.
40. Ouwenhand AC. Antimicrobial components from lactic acid bacteria. In: Salminen S, von Wright A, eds. Lactic Acid Bacteria - Microbiology and Functional Aspects. New York: Marcel Dekker;1988:139-159.
41. Lindgren SE, Dobrogosz WJ. Antagonistic activities of lactic acid bacteria in food and feed fermentations. FEMS Microbiol Rev. 1990;87:149-164.
42. Madsen K, Cornish A, Soper P, et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology. 2001;121:580-591.
43. Brand S, Reinecker H. An enhanced barrier is a better defense: Effects of probiotics on intestinal barrier function. Inflamm Bowel Dis. 2002;8:67-69.
44. Neish AS, Gewirtz AT. Rao AS, et al. Non-pathogenic bacteria may block epithelial responses: Attenuation of IKB ubiquitination as a novel, physiologic mode of anti-inflammation. Gastroenterology. 2000;118:A3754.
45. Schultz M, Linde H, Staudner H, et al. Oral administration of Lactobacillus GG induces an anti-inflammatory, Th-2 mediated systemic immune response towards intestinal organisms. Gastroenterology. 2000;118:A4180.
46. O'Mahony L, Feeney M, MacSharry J, et al. Probiotics, mononuclear cells, and epithelial cells: an anti-inflammatory network. Gastroenterology. 2000;118: A680.
47. Malin M, Suomalainen H, Saxelin M, et al. Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG. Ann Nutr Metab. 1996;40:137-145.
48. Helwig U, Rizzello F, Cifone G, et al. Elevated IL-10 levels in pouch-tissue after probiotic therapy. Immunol Lett. 1999;69:159.